

| Numéro de catalogue | DB265018 |
|---|---|
| Description |
Icrucumab ELISA Kit (DB265018) — Quantitative sandwich ELISA for Icrucumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| Type d'échantillon | Plasma, Serum |
| Sensibilité | 0.156 μg/ml |
| Plage | 0.31-5 μg/mL |
| Numéro d'accès | P17948 |
| Applications | ELISA |
| Méthode de détection | Colorimetric |
| Type de test | Quantitative |
| Retraitement | 80-120% |
| Expédition | 2-8 ℃ |
| Stabilité et stockage | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Spécifications | Icrucumab |
| Noms alternatifs | 18F1, IMC-18F1, LY3012212, 1024603-92-6 |
| Contexte | Vascular endothelial growth factor receptor 1 (Icrucumab) is a ~150 kDa protein. Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF, and plays an essential role in the development of embryonic vasculature, the regulation of angiogenesis, cell survival, cell migration, macrophage function, chemotaxis, and cancer cell invasion. Acts as a positive regulator of postnatal retinal hyaloid vessel regression. May play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothelial cells. Can promote endothelial cell proliferation, survival and angiogenesis in adulthood. Its function in promoting cell proliferation seems to be cell-type specific. 1. Lesslie, DP. et al. (2006) British journal of cancer 94, 1710-7. PMID: 16685275 |
| Note | For Research Use Only. |

Standard Curve of Icrucumab ELISA Kit




Contactez-nous pour les devis personnalisés, les demandes en gros et tout autre problème.
Courrier : [email protected]


+86-027-65523339
Bâtiment C, No. 666, Rue Shendunsi, Wuhan, 430206, Chine
中文
English
한국어
日本語
Español
Français
Русский